Synovus Financial’s Rentokil RTO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$1.76M Sell
69,577
-155
-0.2% -$3.78K 0.02% 393
2025
Q2
$1.67M Sell
69,732
-73,912
-51% -$1.71M 0.02% 382
2025
Q1
$3.29M Buy
143,644
+42,786
+42% +$1.03M 0.04% 254
2024
Q4
$2.55M Sell
100,858
-89,167
-47% -$2.26M 0.03% 309
2024
Q3
$4.74M Buy
190,025
+89,452
+89% +$2.65M 0.05% 224
2024
Q2
$2.98M Buy
100,573
+659
+0.7% +$18.3K 0.04% 275
2024
Q1
$3.01M Buy
99,914
+753
+0.8% +$20.9K 0.04% 274
2023
Q4
$2.84M Buy
99,161
+467
+0.5% +$13.7K 0.04% 272
2023
Q3
$3.66M Sell
98,694
-932
-0.9% -$35.6K 0.04% 235
2023
Q2
$3.89M Sell
99,626
-7,152
-7% -$280K 0.04% 232
2023
Q1
$3.9M Sell
106,778
-2,581
-2% -$81.5K 0.04% 227
2022
Q4
$3.37M Buy
+109,359
New +$3.39M 0.04% 248

Other funds holding RTO

Synovus Financial's RTO Position: Q3 2025 in Review

Synovus Financial reduced its Rentokil (RTO) stake by 0.22% in Q3 2025, selling an estimated $3.78K and leaving 69,577 shares worth $1.76M. The position accounts for 0.02% of the portfolio, ranked #393.

Synovus Financial first reported a position in RTO in Q4 2022 and has held it in 12 quarters since. The position peaked at $4.74M in Q3 2024. 213 funds tracked by Wall St. Rank hold RTO as of Q3 2025.

  • Synovus Financial held 69,577 shares of Rentokil worth $1.76M as of Q3 2025.
  • Synovus Financial sold 155 Rentokil shares in Q3 2025, an estimated $3.78K.
  • Rentokil made up 0.02% of Synovus Financial's portfolio in Q3 2025, its #393 holding.
  • Synovus Financial first reported a position in Rentokil in Q4 2022 and has held it in 12 quarters since.
  • Synovus Financial's Rentokil position peaked at $4.74M in Q3 2024.
  • 213 funds tracked by Wall St. Rank held Rentokil as of Q3 2025.

Based on Synovus Financial's 13F filing for Q3 2025, filed 7 Nov 2025.